Dana M. Gordon Ph.D. (Past Speaker)

Counseling on business management of intellectual property assets, Dr. Dana Gordon advises leading universities, pharmaceutical companies, and medical device companies on strategic aspects of patent, trademark, copyright, and trade secret protection. Dana’s practice emphasizes patent portfolio strategic planning, and preparation and prosecution of U.S., international and foreign patent applications in the life sciences, including applications focused on small molecules, pharmaceuticals, synthetic methods, molecular diversity, drug discovery, polymers, materials science, and medical devices. He frequently provides clients with due diligence assessments of U.S., international, and foreign patent portfolios in connection with technology transactions and acquisitions. Dana also regularly prepares non-infringement, invalidity and clearance patent opinions in these and other areas.

Reflecting his doctorate in organic chemistry, and his postgraduate chemistry fellowship at Harvard University, Dana has a substantial record of technical accomplishments in the life sciences. He directed an independent research program at Brandeis University focused on the synthesis of small molecule antagonists of retroviruses, multiple drug resistance in cancer and bacteria, and hypertension. His postdoctoral research focused on molecular recognition and self-assembly in solution, and the development and application of synthetic methods using organoindium reagents. Dana’s doctoral research at Yale University focused on synthetic methods and the synthesis of biologically-relevant small molecule and carbohydrate natural products.

Dana was previously Deputy Chair of Foley Hoag’s Intellectual Property Group.